Thomas J. Lamb Product Liability Law Blog

Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance Company

Monday, October 24, 2011 by Thomas J. Lamb

Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance CompanyHere Is Why Aetna Wants To Know Whether You Have Filed A Gallbladder Or A Blood Clot Lawsuit Against Bayerhttp://www.drug-injury.com/druginjurycom/2011/10/aetna-letter-yaz-yasmin-ocella-cardiovascular- injury-pe-dvt-stroke-gallbladder-side-effects.html... Read More
Posted at 11:09 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

New Heart Drug Pradaxa May Be Sending "Early" Drug Safety Signals

Monday, October 17, 2011 by Thomas J. Lamb

New Heart Drug Pradaxa May Be Sending "Early" Drug Safety SignalsISMP Quarterwatch 2010 4th Quarter: Hemorrhages And Thromboembolic Events Have Been Reported To FDAhttp://www.drug-injury.com/druginjurycom/2011/10/pradaxa-blood-clotting-side-effects-pe-dvt-hemor rhage-fda-adverse-events-reports-ismp-quarterwatch.html... Read More
Posted at 10:48 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Safety Of Ortho Evra Birth Control Patch Will Be Subject Of FDA Advisory Committees Meeting

Monday, October 3, 2011 by Thomas J. Lamb

Safety Of Ortho Evra Birth Control Patch Will Be Subject Of FDA Advisory Committees MeetingPossibly Increased Risk Of Blood Clot-Related Side Effects Like PE And DVT Suggested By Postmarketing Studieshttp://www.drug-injury.com/druginjurycom/2011/09/ortho-evra-fda-advisory-committees-meeting-d rug-safety-risks-blood-clots.html... Read More
Posted at 10:19 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism

Thursday, September 29, 2011 by Thomas J. Lamb

YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary EmbolismEarly Results Suggest An Approximately 1.5-fold Increase In The Risk For Birth Control Pills With Drospirenone (DRSP) http://www.drug-injury.com/druginjurycom/2011/09/fda-birth-control-study-blood-clots-drospirenone-dr sp-yasmin-yaz-ocella.html... Read More
Posted at 10:42 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

European Medicines Agency (EMA) Recommends Multaq Use Should Be Restricted For Safety Reasons

Tuesday, September 27, 2011 by Thomas J. Lamb

European Medicines Agency (EMA) Recommends Multaq Use Should Be Restricted For Safety ReasonsEMA Cites The Increased Risks Of Liver Injury, Lung Side Effects, And Cardiovascular Adverse Eventshttp://www.drug-injury.com/druginjurycom/2011/09/multaq-safety-review-fda-ema-restriction-regu latory-action-drug-recall.html... Read More
Posted at 10:10 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Many Patients Mistakenly Believe That A Prescription Drug Must Be Safe If FDA-Approved

Monday, September 26, 2011 by Thomas J. Lamb

Many Patients Mistakenly Believe That A Prescription Drug Must Be Safe If FDA-ApprovedSafety Problems With New Medications Often Appear Only After Approval And Widespread Usehttp://www.drug-injury.com/druginjurycom/2011/09/fda-approval-of-prescription-drug-does-not-guara ntee-there-will-be-no-serious-side-effects.html... Read More
Posted at 09:53 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

September 2011: Two FDA Advisory Committees Will Discuss The Safety Of Long-Term Use Of Fosamax, Boniva, And Actonel

Friday, September 9, 2011 by Thomas J. Lamb

September 2011: Two FDA Advisory Committees Will Discuss The Safety Of Long-Term Use Of Fosamax, Boniva, And ActonelOsteonecrosis Of The Jaw, Or Jawbone Death, And Atypical Femur Fractures, Or Low-Stress Thigh Bone Breaks, Are The Primary Drug-Safety Issueshttp://www.drug-injury.com/druginjurycom/2011/09/bisphosphonates-fda-advisory-committees-joint -meeting-fosamax-boniva-actonel-safety-risks-side-effects.html... Read More
Posted at 09:49 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Public Citizen Group Files FDA Petition To Fix Problems Exposed By Mensing Case Ruling

Wednesday, September 7, 2011 by Thomas J. Lamb

Public Citizen Group Files FDA Petition To Fix Problems Exposed By Mensing Case RulingGeneric Drug Companies Should Have To Update Side Effect Warnings Or Face Drug Injury Lawsuitshttp://www.drug-injury.com/druginjurycom/2011/09/public-citizen-petition-fda-generic-drug-ma nufacturers-warnings-side-effects-mensing-supreme-court.html... Read More
Posted at 09:54 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Next Fosamax Jaw Injury Lawsuit Trial, Secrest v. Merck, Scheduled To Start In Early September 2011

Wednesday, August 31, 2011 by Thomas J. Lamb

Next Fosamax Jaw Injury Lawsuit Trial, Secrest v. Merck, Scheduled To Start In Early September 2011Federal Court Judge Keenan Wants Two More Fosamax - ONJ Bellwether Cases To Go To Jury Verdict After This Trialhttp://www.drug-injury.com/druginjurycom/2011/08/fosamax-mdl-onj-secrest-merck-trial-federal-co urt-judge-keenan.html... Read More
Posted at 10:02 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation

Multaq: August 2011 Update: Another Liver Failure Case Report Article In Medical Journal

Tuesday, August 23, 2011 by Thomas J. Lamb

Multaq: August 2011 Update: Another Liver Failure Case Report Article In Medical JournalNew Sanofi "Dear Doctor" Letter: Label Change Regarding Heart-Related Side Effects Coming Soonhttp://www.drug-injury.com/druginjurycom/2011/08/multaq-dear-doctor-letters-liver-failure-heart- related-side-effects-label-change.html... Read More
Posted at 10:00 AM  |  PERMALINK
Topic: Drug and Medical Device Litigation
« previous page   (Page 1 of 17, totaling 165 entries)   next page »